US-listed companies are likely to see their share prices tumble if they are forced to admit having inadequate internal controls by the Sarbanes-Oxley Act, research has found.

Three-quarters of investors and analysts said they were likely to sell or mark down the shares of companies that reported ineffective internal controls against fraud, research by Mori and PwC revealed.